| Product Code: ETC8272224 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Antithrombotic Drugs Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Mexico Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Mexico Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Mexico Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Mexico Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Mexico Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Mexico Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Mexico |
4.2.2 Growing awareness about the importance of antithrombotic drugs in preventing strokes and heart attacks |
4.2.3 Rising geriatric population in Mexico leading to higher demand for antithrombotic drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Mexico |
4.3.2 High cost associated with antithrombotic drugs limiting accessibility for some population segments |
5 Mexico Antithrombotic Drugs Market Trends |
6 Mexico Antithrombotic Drugs Market, By Types |
6.1 Mexico Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Mexico Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Mexico Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Mexico Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Mexico Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Mexico Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Mexico Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Mexico Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Mexico Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Mexico Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Mexico Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Mexico Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Mexico Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Mexico Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Mexico Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Mexico Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Mexico Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Mexico Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Mexico Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Mexico Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Mexico Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Mexico Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Mexico Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Mexico Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Mexico Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Mexico Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Mexico Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Mexico Antithrombotic Drugs Market Export to Major Countries |
7.2 Mexico Antithrombotic Drugs Market Imports from Major Countries |
8 Mexico Antithrombotic Drugs Market Key Performance Indicators |
8.1 Average number of prescriptions for antithrombotic drugs per month |
8.2 Percentage of patients with cardiovascular diseases prescribed antithrombotic drugs |
8.3 Number of healthcare facilities offering antithrombotic drugs in Mexico |
9 Mexico Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Mexico Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Mexico Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Mexico Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Mexico Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Mexico Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Antithrombotic Drugs Market - Competitive Landscape |
10.1 Mexico Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Mexico Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here